投資評等
最後更新日期:2025/5/11
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2012/1/3 | Barclays Capital | Equal Weight >> Overweight | $6 >> $7 |
2010/3/18 | Kaufman Bros | Hold >> Buy | $5.50 >> $8 |
2009/10/9 | Barclays Capital | Underweight >> Equal Weight | |
2009/9/25 | Deutsche Securities | Hold >> Buy | |
2009/3/3 | FBR Capital Markets | Mkt Perform Outperform | 4 |
2006/5/4 | Lehman Brothers | Equal-weight Overweight | 14 |
2005/4/28 | Merrill Lynch | Sell->Neutral | |
2005/1/27 | Smith Barney Citigroup | Sell->Hold | 6.5 |
2003/8/18 | Smith Barney Citigroup | Underperform -> In-line | 11 |
2003/7/24 | Wachovia | Mkt Perform -> Outperform | |
2003/7/1 | Morgan Stanley | Underweight -> Equal-weight | |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2013/12/16 | Mizuho | Buy >> Neutral | $10 >> $11.15 |
2013/2/26 | FBR Capital | Outperform >> Mkt Perform | 8 |
2011/9/28 | Avian | Positive >> Neutral | |
2011/1/12 | Deutsche Bank | Buy >> Hold | $6 >> $6.50 |
2007/10/26 | Lehman Brothers | Overweight Equal-weight | |
2005/11/8 | Lehman Brothers | Overweight->Equal-weight | |
2004/9/14 | Wachovia | Outperform >> Mkt Perform | |
2003/1/23 | Morgan Stanley | Equal-weight -> Underweight | |
2002/10/7 | Prudential | Buy -> Hold | 13 |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2012/7/2 | Mizuho | Buy | 10 |
2011/6/20 | Barclays Capital | Equal Weight | 7 |
2009/3/24 | Deutsche Securities | Hold | |
2009/3/19 | Wedbush Morgan | Buy | |
2007/5/10 | Deutsche Securities | Hold | 9 |
2007/3/27 | Am Tech/JSA Research | Buy | 13 |
2006/9/15 | Longbow | Buy | 11 |
2006/6/21 | Kaufman Bros | Buy | 11 |
2005/8/12 | Wedbush Morgan | Buy | 13 |
2005/8/10 | Fulcrum | Buy | |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2011/9/13 | Wedbush | Neutral | $8 >> $7 |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2012/11/20 | UBS | Neutral | $7.50 >> $7 |
2012/5/29 | Barclays | Overweight | $12 >> $10 |
2012/5/29 | Maxim Group | Buy | $12 >> $8 |
2012/3/15 | Barclays Capital | Overweight | $10 >> $12 |
2011/7/28 | Barclays Capital | Equal Weight | $7 >> $8 |
2010/12/15 | UBS | Neutral | $5 >> $6 |
2010/10/28 | Wedbush | Outperform | $8 >> $7 |
2010/9/29 | FBR Capital | Mkt Perform | $6.25 >> $6 |
2010/7/30 | UBS | Neutral | $8.50 >> $5 |
2010/7/29 | FBR Capital | Outperform | $7.50 >> $6.25 |